Sunshine Lake Pharma
As of the edition of 20 October 2026, Sunshine Lake Pharma runs 25 drugs; it is on route A at 6 targets and on route B at 0 targets.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 9 |
| Went quiet | 5 |
| Stopped | 4 |
| Status not established | 7 |
| Total | 25 |
Where it needs a new molecule
Route A at 6 targets, route B at 0 targets.
All 6 rows on route A or B
In the product6 company-target rows on route A or B; 3 are not shown here, and no score is.
See all 6 targets where Sunshine Lake Pharma needs a new molecule, with the facts behind eachRequest access. Nothing is shown until you do.
Where its trials are
- Digestive system: 14 trials led
- Lungs and airways: 9 trials led
- Infections: 7 trials led